With current quarterly
share price growth of 12.5 percent and five - year growth projected to be 13 percent, CarMax is a good long - term play.
We believe
share price growth of 20 percent to 30 percent is very much in the cards here.
Not exact matches
The Sunnyvale, Calif. company's lucrative piece
of the Chinese e-commerce company (BABA) has done wonders for its coffers and
share price but lately has sent it into an existential crisis as investors seek
growth from the beleaguered company.
Huber
of T. Rowe
Price foresees high - single - digit earnings - per - share growth, and 15 % share - price upside in the next couple of years, even before factoring in y
Price foresees high - single - digit earnings - per -
share growth, and 15 %
share -
price upside in the next couple of years, even before factoring in y
price upside in the next couple
of years, even before factoring in yield.
Currently, the company is trading at about 25 times earnings and with a long - term earnings per
share growth rate
of about 15 %, its
price - to - earnings to
growth ratio — a metric used to value fast growing companies — is about 1.4.
Certainly no one is predicting large declines in profits or
share prices, but rather a period
of much more modest
growth.
And the follow - through into corporate earnings and, importantly, revenue
growth certainly was supportive
of share prices.
Seeking to appease investors with boosts to
share prices, CEOs are prioritizing short - term returns at the expense
of R&D, workforce training and other investments essential to their companies» long - term
growth.
When you purchase a broad swath
of equities, say an S&P 500 index fund, the returns you can expect over the next decade or so comprise four building blocks: the starting dividend yield, projected
growth in real earnings per
share, expected inflation, and the expected change in «valuation» — that is, the expansion or contraction in the
price / earnings (P / E) multiple.
Collect a Check When stock
price growth is sluggish, dividends account for a much bigger
share of investors» gains.
Such risks, uncertainties and other factors include, without limitation: (1) the effect
of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity
prices, interest rates and foreign currency exchange rates, levels
of end market demand in construction and in both the commercial and defense segments
of the aerospace industry, levels
of air travel, financial condition
of commercial airlines, the impact
of weather conditions and natural disasters and the financial condition
of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization
of the anticipated benefits
of advanced technologies and new products and services; (3) the scope, nature, impact or timing
of acquisition and divestiture or restructuring activity, including the pending acquisition
of Rockwell Collins, including among other things integration
of acquired businesses into United Technologies» existing businesses and realization
of synergies and opportunities for
growth and innovation; (4) future timing and levels
of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability
of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope
of future repurchases
of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level
of other investing activities and uses
of cash, including in connection with the proposed acquisition
of Rockwell; (7) delays and disruption in delivery
of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits
of organizational changes; (11) the anticipated benefits
of diversification and balance
of operations across product lines, regions and industries; (12) the outcome
of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact
of the negotiation
of collective bargaining agreements and labor disputes; (15) the effect
of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect
of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect
of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act
of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability
of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition
of conditions that could adversely affect the combined company or the expected benefits
of the merger) and to satisfy the other conditions to the closing
of the pending acquisition on a timely basis or at all; (18) the occurrence
of events that may give rise to a right
of one or both
of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee
of $ 695 million to United Technologies or $ 50 million
of expense reimbursement; (19) negative effects
of the announcement or the completion
of the merger on the market
price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation
of their businesses while the merger agreement is in effect; (21) risks relating to the value
of the United Technologies»
shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability
of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
Dip in
share prices and bond yields, along with the upcoming election has had an impact on the state
of the global economy, causing a setback in business travel
growth.
If Netflix sees high revenue increases over the next couple
of years, based on strong subscriber
growth, customer retention, and low marketing spend, he predicts the
share price could reach $ 480.
Because
of the likelihood that pursuing an acquisition will boost a company's revenue
growth and thus its
share price, investors have increasingly been pressuring pharmaceutical firms such as Gilead Sciences (GILD) and Teva to strike deals.
During his tenure with AlliedSignal, the company achieved consistent
growth in earnings and cash flow, highlighted by 31 consecutive quarters
of earnings - per -
share growth of 13 % or more and an eight-fold appreciation
of the company's
share price.
The company's financial performance in the year to date has been mixed after its decision to raise the
prices of its products weakened its market
share and forced it to trim its sales
growth forecast for the full year.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain
growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market
share and
price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect
of lowering
prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its
share repurchase program due to changes in its stock
price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
But anyone hoping for the kind
of stock
growth Shoppers enjoyed over the past decade — when its
share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.
The company's strengths can be seen in multiple areas, such as its solid stock
price performance, impressive record
of earnings per
share growth, compelling
growth in net income, robust revenue
growth and notable return on equity.
I like this screener because it gives you a solid base
of criteria — allowing you to sort by sector, exchange,
share price, market cap, earnings per
share, annual income
growth, institutional holdings, and other key metrics — while also giving you access to all Canadian exchanges.
At its current valuation
of ~ $ 67 /
share, HLF has a
price to economic book value ratio (
price - to - EBV)
of 1.2 That ratio means that the market expects only 20 %
growth in NOPAT for the remainder
of HLF's existence.
The Compensation Committee believes that options to purchase
shares of our common stock, with an exercise
price equal to the market
price of our common stock on the date
of grant, are inherently performance - based and are a very effective tool to motivate our executives to build stockholder value and reinforce our position as a
growth company.
The immediate question raised by a fall in
share prices of that sort
of order is the size
of its impact on global
growth.
Indeed, the strong
growth of investor housing loans has driven the
growth in household debt (as a
share of disposable incomes) over recent years and contributed to a rise in both housing
prices and dwelling construction.
Under the Bonus Plan, our compensation committee, in its sole discretion, determines the performance goals applicable to awards, which goals may include, without limitation: attainment
of research and development milestones, sales bookings, business divestitures and acquisitions, cash flow, cash position, earnings (which may include any calculation
of earnings, including but not limited to earnings before interest and taxes, earnings before taxes, earnings before interest, taxes, depreciation and amortization and net earnings), earnings per
share, net income, net profit, net sales, operating cash flow, operating expenses, operating income, operating margin, overhead or other expense reduction, product defect measures, product release timelines, productivity, profit, return on assets, return on capital, return on equity, return on investment, return on sales, revenue, revenue
growth, sales results, sales
growth, stock
price, time to market, total stockholder return, working capital, and individual objectives such as MBOs, peer reviews, or other subjective or objective criteria.
The ranking is comprised
of 10 companies from each
of the five industry sectors, and they were selected based on three equally weighted criteria: market capitalization
growth,
share price appreciation and trading volume.
The economic effects can be seen in a number
of areas including strong
growth in business investment, company profits,
share prices and imports.
At its new
price of ~ $ 23 /
share, the market expects 10 % compounded annual NOPAT
growth for the next 11 years.
While the liberalizing reforms usually undermine the ability
of the elite to capture a disproportionate
share of growth, in other words, because the reforms often seem to encourage massive foreign capital inflows, and these push up the
price of assets largely controlled by the elite, political opposition to the reforms is weakened.
Figure 1 shows this value - destroying behavior in action for GE (GE) by comparing between the amount
of money spent buying back
shares and the
price to economic book value (PEBV), a measure
of the
growth expectations embedded in the stock
price.
While the $ 2.36 per
share offer only implies a «small» 15 per cent takeover premium to Deutsche's $ 2.05
price target, the research team points to «recent operational risks in the hospital portfolio, the execution risks
of the Northern Beaches greenfield project and our lower revenue
growth outlook for the private hospital industry.»
Any feedback into
prices is dampened by the low level
of wage
growth, rebalancing
of factor
shares, and a relatively low correlation that has developed over time re the
price - wage relationship.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its products from other brands; the consolidation
of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue
growth in its key product categories, increase its market
share, or add products; an impairment
of the carrying value
of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution
of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement actions; product recalls or product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility
of capital markets; increased pension, labor and people - related expenses; volatility in the market value
of all or a portion
of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts
of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations;
pricing actions; and other factors.
In 2015, news reports revealed that Uber had an operating loss
of $ 470 million on $ 415 million in revenue, confirming suspicions that the company has been bleeding money for the sake
of achieving steep
growth and acquiring market
share.391 In China, the company has lost more than $ 1 billion a year.392 The strategy
of aggressive
price competition and brazen leadership coupled with soaring
growth prompted immediate comparisons to Amazon.393 Like Amazon, Uber has drawn immense interest from investors.
Examples
of forward - looking statements include, but are not limited to, statements we make regarding the Company's plans, assumptions, expectations, beliefs and objectives with respect to store openings and closings; product introductions; sales; sales
growth; sales trends; store traffic; retail
prices; gross margin; operating margin; expenses; interest and other expenses, net; effective income tax rate; net earnings and net earnings per
share;
share count; inventories; capital expenditures; cash flow; liquidity; currency translation;
growth opportunities; litigation outcomes and recovery related thereto; the collectability
of amounts due under financing arrangements with diamond mining and exploration companies; and certain ongoing or planned product, marketing, retail, manufacturing, information systems development, upgrades and replacement, and other operational and strategic initiatives.
Style Categories: Large Cap, Mid Cap, Small Cap,
Growth, Value, Grth / Val or Blend («Cap» denotes capitalization, which is market
price per
share times number
of common stock
shares outstanding).
Taking account
of all this,
share prices seem to assume there will be an implausible rate
of growth in profits.
NEW YORK (TheStreet)-- The sales
growth — and
share price —
of Dunkin' Brands (DNKN) may be one initial casualty
of higher minimum wages being adopted across the country.
IF INFORMATION technology is lifting America's rate
of growth, surely that justifies the current lofty heights
of share prices?
Much
of the record
growth in corporate EPS has been driven by lower interest expense, lower commodity
prices and
share buybacks as top line
growth has been sub-par.
Shares of Dunkin' slid 12 % on Thursday as it reported slowing sales
growth in the third quarter, when menu
prices were raised by franchisees following a contentious summer
of minimum wage discussions in the country.
But even if America's future average economic
growth is as steep as optimists believe, say just over 4 % a year, the current level
of share prices implies that profits will rise even faster.
Mac — in a declining PC industry, we expect Mac to continue its market
share gain and support our forecast for its strong performance
of 7.3 % revenue
growth in FY 2015, followed by 3.6 % in FY 2016, and 4.6 % in FY 2017 on flat average selling
prices over the three year period
of $ 1,230.
Bought in 2012 at $ 37 /
share and annual dividend of $ 1.44 2015 share price of $ 79 / share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =
share and annual dividend
of $ 1.44 2015
share price of $ 79 / share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =
share price of $ 79 /
share and annual dividend of $ 1.84 Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =
share and annual dividend
of $ 1.84
Share price capital gain = 113 %, Total dividend growth = 27.7 % Prune Ratio: 113 / 27.7 =
Share price capital gain = 113 %, Total dividend
growth = 27.7 % Prune Ratio: 113 / 27.7 = 4.03
«Boards that authorise
share - repurchase initiatives at market
prices below what the businesses are intrinsically worth per
share (without foregoing investment in even more compelling
growth opportunities and with due regard for the financial security
of the remaining shareholders) are clearly putting the shareholder's interest high on the priority list» Frank Martin
Bought in 2013 at $ 77 /
share and annual dividend of $ 2.40 2015 share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =
share and annual dividend
of $ 2.40 2015
share price of $ 80 / share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =
share price of $ 80 /
share and annual dividend of $ 2.65 Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =
share and annual dividend
of $ 2.65
Share price total return = 3 %, Total Dividend Growth = 10.4 % Prune Ratio: 3 / 10.4 =
Share price total return = 3 %, Total Dividend
Growth = 10.4 % Prune Ratio: 3 / 10.4 = 0.28
Enterprise to drive
growth With 34 %
of total revenue, the enterprise and infrastructure business is a key driver
of earnings and
share price growth for Jabil.
If you solve for»n' such that the present value
of the cash flows is equal to the
share price you get an indication
of the
growth rate implied in the stock
price.
Bought in 2011 at $ 12.22 /
share and annual dividend of $ 0.63 2015 share price at $ 16.44 / share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =
share and annual dividend
of $ 0.63 2015
share price at $ 16.44 / share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =
share price at $ 16.44 /
share and annual dividend of $ 0.67 Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =
share and annual dividend
of $ 0.67
Share price capital gain = 32 %, Total dividend growth = 6.9 % Prune Ratio: 32 / 6.9 =
Share price capital gain = 32 %, Total dividend
growth = 6.9 % Prune Ratio: 32 / 6.9 = 4.63
A strengthening dollar and the hangover
of weak energy
prices will likely hold back earnings - per -
share growth.